162 related articles for article (PubMed ID: 19197536)
1. Expression of retinoid-regulated genes in lamellar ichthyosis vs. healthy control epidermis: changes after oral treatment with liarozole.
Pavez Loriè E; Gånemo A; Borgers M; Wouters L; Blockhuys S; van de Plassche L; Törmä H; Vahlquist A
Acta Derm Venereol; 2009; 89(1):12-20. PubMed ID: 19197536
[TBL] [Abstract][Full Text] [Related]
2. Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.
Zeng Q; Smith DC; Suscovich TJ; Gooding WE; Trump DL; Grandis JR
Clin Cancer Res; 2000 Jun; 6(6):2245-51. PubMed ID: 10873074
[TBL] [Abstract][Full Text] [Related]
3. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study.
Verfaille CJ; Vanhoutte FP; Blanchet-Bardon C; van Steensel MA; Steijlen PM
Br J Dermatol; 2007 May; 156(5):965-73. PubMed ID: 17263800
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
Pavez Loriè E; Cools M; Borgers M; Wouters L; Shroot B; Hagforsen E; Törmä H; Vahlquist A
Br J Dermatol; 2009 Jan; 160(1):26-36. PubMed ID: 19016711
[TBL] [Abstract][Full Text] [Related]
5. Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial.
Vahlquist A; Blockhuys S; Steijlen P; van Rossem K; Didona B; Blanco D; Traupe H
Br J Dermatol; 2014 Jan; 170(1):173-81. PubMed ID: 24102348
[TBL] [Abstract][Full Text] [Related]
6. Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis.
Pavez Loriè E; Chamcheu JC; Vahlquist A; Törmä H
Arch Dermatol Res; 2009 Aug; 301(7):475-85. PubMed ID: 19294396
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole.
Lucker GP; Heremans AM; Boegheim PJ; van de Kerkhof PC; Steijlen PM
Br J Dermatol; 1997 Jan; 136(1):71-5. PubMed ID: 9039298
[TBL] [Abstract][Full Text] [Related]
8. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
Van Wauwe J; Van Nyen G; Coene MC; Stoppie P; Cools W; Goossens J; Borghgraef P; Janssen PA
J Pharmacol Exp Ther; 1992 May; 261(2):773-9. PubMed ID: 1374473
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of immunoreactive involucrin in lamellar ichthyosis.
Peña-Penabad C; de Unamuno P; García Silva J; Ludeña MD; González Sarmiento R; Pérez-Arellano JL
Eur J Dermatol; 1999; 9(3):197-201. PubMed ID: 10210784
[TBL] [Abstract][Full Text] [Related]
10. Keratin 4 upregulation by retinoic acid in vivo: a sensitive marker for retinoid bioactivity in human epidermis.
Virtanen M; Törmä H; Vahlquist A
J Invest Dermatol; 2000 Mar; 114(3):487-93. PubMed ID: 10692107
[TBL] [Abstract][Full Text] [Related]
11. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
Kuijpers AL; Van Pelt JP; Bergers M; Boegheim PJ; Den Bakker JE; Siegenthaler G; Van de Kerkhof PC; Schalkwijk J
Br J Dermatol; 1998 Sep; 139(3):380-9. PubMed ID: 9988537
[TBL] [Abstract][Full Text] [Related]
12. Leiomyoma fibrosis inhibited by liarozole, a retinoic acid metabolic blocking agent.
Gilden M; Malik M; Britten J; Delgado T; Levy G; Catherino WH
Fertil Steril; 2012 Dec; 98(6):1557-62. PubMed ID: 22925684
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 1-deficient recessive lamellar ichthyosis associated with a LINE-1 insertion in Jack Russell terrier dogs.
Credille KM; Minor JS; Barnhart KF; Lee E; Cox ML; Tucker KA; Diegel KL; Venta PJ; Hohl D; Huber M; Dunstan RW
Br J Dermatol; 2009 Aug; 161(2):265-72. PubMed ID: 19438474
[TBL] [Abstract][Full Text] [Related]
14. Short term 13-cis-retinoic acid treatment at therapeutic doses elevates expression of leptin, GLUT4, PPARgamma and aP2 in rat adipose tissue.
Krskova-Tybitanclova K; Macejova D; Brtko J; Baculikova M; Krizanova O; Zorad S
J Physiol Pharmacol; 2008 Dec; 59(4):731-43. PubMed ID: 19212007
[TBL] [Abstract][Full Text] [Related]
15. New mutations in the transglutaminase 1 gene in three families with lamellar ichthyosis.
Cao X; Lin Z; Yang H; Bu D; Tu P; Chen L; Wu H; Yang Y
Clin Exp Dermatol; 2009 Dec; 34(8):904-9. PubMed ID: 19486042
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole.
Dockx P; Decree J; Degreef H
Br J Dermatol; 1995 Sep; 133(3):426-32. PubMed ID: 8546999
[TBL] [Abstract][Full Text] [Related]
17. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo.
Kang S; Duell EA; Kim KJ; Voorhees JJ
J Invest Dermatol; 1996 Aug; 107(2):183-7. PubMed ID: 8757760
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment with topical N-acetylcysteine in urea in five children with congenital lamellar ichthyosis.
Bassotti A; Moreno S; Criado E
Pediatr Dermatol; 2011; 28(4):451-5. PubMed ID: 21793884
[TBL] [Abstract][Full Text] [Related]
19. Topical liarozole in ichthyosis: a double-blind, left-right comparative study followed by a long-term open maintenance study.
Lucker GP; Verfaille CJ; Heremans AM; Vanhoutte FP; Boegheim JP; Steijlen PP
Br J Dermatol; 2005 Mar; 152(3):566-9. PubMed ID: 15787831
[No Abstract] [Full Text] [Related]
20. Treatment of psoriasis with oral liarozole: a dose-ranging study.
Berth-Jones J; Todd G; Hutchinson PE; Thestrup-Pedersen K; Vanhoutte FP
Br J Dermatol; 2000 Dec; 143(6):1170-6. PubMed ID: 11122017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
